Have a personal or library account? Click to login

Recomandările naționale ale Societății Croate de Biochimie și Medicină de Laborator pentru recoltarea, prelucrarea probelor de sânge, performanța testării și raportarea rezultatelor pentru testele screening de hemostază: timp de protrombină, timp de tromboplastină parțială activată, timp de trombină, fibrinogen și D-dimeri

Open Access
|Nov 2024

References

  1. Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New Fundamentals in Hemostasis. Physiol Rev. 2013;93:327-58. DOI: 10.1152/physrev.00016.2011
  2. Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb). 2010;20:184-99. DOI: 10.11613/BM.2010.023
  3. Harris NS, Bazydlo LAL, Winter WE. A Primer on Haemostasis for Clinical Chemists.Clinical Laboratory News 2012. Available at: https://www.aacc.org/publications/cln/articles2012/January/coagulation-tests. Accessed March 17th 2016.
  4. Chandler WL, ed. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 63-71. DOI: 10.1002/9781444303575.ch7
  5. Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in haemostasis. Lab Med. 2012;43:1-10. DOI: 10.1309/LM749BQETKYPYPVM
  6. Bronić A, Coen Herak D, Margetić S, Milić M. Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb). 2017;27:199-216. DOI: 10.11613/BM.2017.022
  7. Lippi G, Favaloro EJ, eds. Causes of errors in medical laboratories. In Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 22-31. DOI: 10.1002/9781118543467.ch3
  8. Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49. DOI: 10.1186/s12959-016-0123-z
  9. Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017;1646:29-42. DOI: 10.1007/978-1-4939-7196-1_2
  10. Nikolac N, Šupak-Smolčić V, Šimundić AM, Ćelap I. Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling. Biochem Med (Zagreb). 2013;23:242-54. DOI: 10.11613/BM.2013.031
  11. Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline-Fifth Edition. CLSI document H21-A5. Wayne: CLSI; 2008.
  12. Adcock DM, Kressin DC, Marlar RA. Minimum Specimen Volume Requirements for Routine Coagulation Testing Dependence on Citrate Concentration. Am J Clin Pathol. 1998;109;595-9. DOI: 10.1093/ajcp/109.5.595
  13. Bennett ST, ed. Collection of Coagulation Specimens. In: Bennett ST, Lehman CM, Rodgers GM, eds. Laboratory Hemostasis - A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2015. p.19-32. DOI: 10.1007/978-3-319-08924-9_2
  14. Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Gu- idi GC, Favaloro EJ. Quality Standards for Sample Collection in Coagulation Testing. Semin Thromb Hemost. 2012;38: 565-75. DOI: 10.1055/s-0032-1315961
  15. Laxson CJ, Titler MG. Drawing coagulation studies from arterial lines; an integrative literature review. Am J Critical Care. 1994;3:16-22. DOI: 10.4037/ajcc1994.3.1.16
  16. Adcock Funk D, ed. Sample integrity and preanalytical variables. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 45-56. DOI: 10.1002/9781118543467.ch5
  17. Suchsland J, Friedrich N, Grotevendt A, Kallner A, Lüdemann J, Nauck M, Petersmann A. Optimizing centrifugation of coagulation samples in laboratory automation. Clin Chem Lab Med. 2014;52:1187-91. DOI: 10.1515/cclm-2014-0038
  18. Marlar RA, Potts MR, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol. 2006;126:400-5. DOI: 10.1309/RRQKT2JEYV33D19D
  19. Lippi G, Plebani M, Favarolo EJ. Interference in coagulation testing: Focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2013;39:258-66. DOI: 10.1055/s-0032-1328972
  20. Adcock Funk DM, Lippi G, Favaloro EJ. Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing. Semin Thromb Hemost. 2012;38:576-85. DOI: 10.1055/s-0032-1319768
  21. van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-Site blood collection: Influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8. DOI: 10.1373/clinchem.2004.043174
  22. Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand Disorder due to cold activation of blood samples for testing. Am J Clin Path. 2004;122;686-92. DOI: 10.1309/E4947DG48TVY19C2
  23. Lima-Oliveira G, Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Clin Biochem. 2016;49:1399-401. DOI: 10.1016/j.clinbiochem.2016.10.009
  24. Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effects of storage and thawing conditions on coagulation testing. Int J Lab Hematol. 2015;37:551-9. DOI: 10.1111/ijlh.12342
  25. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M; British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 2013;35:1-13. DOI: 10.1111/ijlh.12004
  26. Gardiner C, Kitchen S, Dauer RJ, Kottke-Marchant K, Adcock DM. Recommendations for evaluation of coagulation analyzers. Lab Hematol. 2006;12:32-8. DOI: 10.1532/LH96.05031
  27. Kitchen S, Preston EF, Olson JD, eds. Internal Quality Control in the hemostasis Laboratory. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 57-64. DOI: 10.1002/9781118543467.ch6
  28. Preston EF, Kitchen S, Srivastava A, eds. External Quality Assessment in Hemostasis: Its Importance and Significance. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 65-76. DOI: 10.1002/9781118543467.ch7
  29. Clinical and Laboratory Standard Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline-Second Edition H47-A2, Wayne: CLSI; 2008.
  30. Tripodi A, ed. Monitoring Oral Anticoagulant Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 253-63. DOI: 10.1002/9781118543467.ch22
  31. Bonar R, Favaloro EJ. Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio. Thromb Res. 2017;150:22-9. DOI: 10.1016/j. thromres.2016.12.007
  32. Clinical and Laboratory Standards Institute (CLSI). Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline. CLSI guideline H54-A. Wayne: CLSI; 2005.
  33. Croatian Chamber of Medical Biochemists. [Harmonizacija laboratorijskih nalaza u području opće medicinske biokemije.] Available at: http://www.hkmb.hr/obavijesti/obavije-sti-index.html. Accessed March 21th 2016. (in Croatian).
  34. Lippi G, Favaloro EJ. Activated partial thromboplastin time: New tricks for an old dogma. Semin Thromb Hemost. 2008;34:604-11. DOI: 10.1055/s-0028-1104539
  35. Johnston M, ed. Monitoring Heparin Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 224-52. DOI: 10.1002/9781118543467.ch21
  36. Brill-EdvardsP, Gunsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-9. DOI: 10.7326/0003-4819-119-2-199307150-00002
  37. Marlar RA, Gausman J. The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time - based heparin therapeutic range. Arch Pathol Lab Med. 2013;137:77-82. DOI: 10.5858/arpa.2011-0516-OA
  38. Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy; the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998;122:799-807
  39. Rodgers GM, Lehman CM, eds. Hemostasis Screening Assays. In: Bennett ST, Lehman CM, Rodgers GM. Laboratory Hemostasis: A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2007.p.85-101. DOI: 10.1007/0-387-36840-X_5
  40. Teruya J. Thrombin Time. Available at: https://emedicine.medscape.com/article/2086278-overview . Accessed March 21th 2016.
  41. Ariëns RA. Fibrin(ogen) and thrombotic disease. J Thromb Haemost. 2013;11:294-305. DOI: 10.1111/jth.12229
  42. Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. On Behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003;121:396-404. DOI: 10.1046/j.1365-2141.2003.04256.x
  43. van den Besselaar AMHP, van Rijn CJJ, Cobbaert CM, Reijnierse GLA, Hollestelle MJ, Niessen R. et al. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples. Clin Chem Lab Med. 2017; 55:1761-9. DOI: 10.1515/cclm-2016-1088
  44. Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126:e428-33. DOI: 10.1016/j.thromres.2010.09.004
  45. Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the “derived” fibrinogen measurement. Blood Coagul Fibrinol. 1994;5:955-7. DOI: 10.1097/00001721-199412000-00012
  46. Olson JD, Cunningham MT, Higgins RA, Eby CS, Brandt JT. D-dimer: simple test, tough problems. Arch Pathol Lab Med. 2013;137:1030-8. DOI: 10.5858/arpa.2012-0296-CP
  47. Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287-93. DOI: 10.1055/s-0035-1549092
  48. Clinical and Laboratory Standards Institute (CLSI). Quantitative D-Dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Wayne: CLSI; 2011.
  49. Oude Elferink RFM, Loot AE, Van de Klashorst CGJ, Hulsebos-Huygen M, Piersma-Wichers M, Oudega R. Clinical evaluation of eight different D-dimer test for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230-8. DOI: 10.3109/00365513.2014.993697
  50. Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97:1507-13. DOI: 10.3324/haematol.2011.060657
  51. Favaloro EJ, Lippi G. Laboratory reporting of haemostasis assays: The final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med. 2010;48:309-21. DOI: 10.1515/CCLM.2010.061
  52. Marlar RA, ed. Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 13-21. DOI: 10.1002/9781118543467.ch2
  53. Castellone DD. Establishing reference intervals in the coagulation laboratory. Int J Lab Hematol. 2017;39:121-27. DOI: 10.1111/ijlh.12661
  54. Ignjatovic V, Kenet G, Monagle P, on behalf of the Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting paediatric samples. J Thromb Haemost. 2012;10:298-300. DOI: 10.1111/j.1538-7836.2011.04584.x
  55. Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54:215-22. DOI: 10.1515/cclm-2015-0657
  56. Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J, Plebani M. IFCC WG harmonization of quality assessment of interpretative comments. Clin Chem Lab Med. 2016;54:1901-11. DOI: 10.1515/cclm-2016-0709
  57. Lippi G, Adcock D, Simundic AM, Tripodi A, Favaloro EJ. Critical laboratory values in hemostasis: toward consensus. Ann Med. 2017;49:455-461. DOI: 10.1080/07853890.2016.1278303
  58. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133:160S-98S. DOI: 10.1378/chest.08-0670
  59. Pai M, Moffat KA, Plumhoff E, Hayward CM. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol. 2011;136:836-41. DOI: 10.1309/AJCP8O8GIPPPNUSH
  60. Don-Wauchope AC, Chetty VT. Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values? Clin Biochem. 2009;42:766-70. DOI: 10.1016/j. clinbiochem.2009.02.016
  61. Huber AR, Méndez A, Brunner-Agten S. Automation in haemostasis. Hamostaseologie. 2013;33:295-8. DOI: 10.5482/HAMO-12-05-0002
DOI: https://doi.org/10.2478/rrlm-2024-0027 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 281 - 296
Published on: Nov 6, 2024
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2024 Ana Bronić, Desiree Coen Herak, Sandra Margetić, Marija Milić, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.